Recent research emphasizes the importance of the tumor immune microenvironment: tumors with “inflamed” profiles (high CD8 + T cell infiltration and interferon-γ gene signatures) are more likely to respond, whereas an immunosuppressive environment, or increased oncofetal gene expression (such as GPC3 and AFP), can drive primary resistance to ICIs. This evidence concerns the gene AFP and neoplasm.